SunTrust Banks Reiterates $82.00 Price Target for Express Scripts (ESRX)
Several other research firms also recently commented on ESRX. BidaskClub upgraded shares of Express Scripts from a hold rating to a buy rating in a report on Thursday. Maxim Group increased their target price on shares of Express Scripts from $78.00 to $87.00 and gave the stock a buy rating in a report on Thursday. ValuEngine raised Express Scripts from a hold rating to a buy rating in a research note on Monday, December 4th. TheStreet raised Express Scripts from a c+ rating to a b- rating in a research note on Monday, December 4th. Finally, Sanford C. Bernstein raised shares of Express Scripts from an underperform rating to a market perform rating in a research report on Wednesday, December 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Express Scripts presently has a consensus rating of Hold and an average target price of $74.40.
Shares of Express Scripts (NASDAQ:ESRX) traded up $2.53 during mid-day trading on Thursday, hitting $71.55. 8,786,136 shares of the stock were exchanged, compared to its average volume of 4,094,484. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market capitalization of $40,523.99, a price-to-earnings ratio of 10.46, a PEG ratio of 1.06 and a beta of 0.88. Express Scripts has a twelve month low of $55.80 and a twelve month high of $73.42.
In other news, VP Phyllis S. Anderson sold 643 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the completion of the acquisition, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. Corporate insiders own 0.68% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Dodge & Cox lifted its stake in shares of Express Scripts by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the last quarter. Pzena Investment Management LLC bought a new stake in shares of Express Scripts during the 2nd quarter worth approximately $181,234,000. Northern Trust Corp lifted its stake in shares of Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after acquiring an additional 1,206,980 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after acquiring an additional 996,816 shares during the last quarter. Finally, Veritas Asset Management LLP raised its position in Express Scripts by 13.2% during the 2nd quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock valued at $523,014,000 after purchasing an additional 952,249 shares in the last quarter. 88.44% of the stock is currently owned by institutional investors.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.